JAKARTA (Indonesia Today) – Pharmaceutical company PT Combined Imperial Pharmaceutical (Combiphar) prioritizes an amicable settlement proposal with PT. Parazelsus Indonesia than proceeding the legal battle.
South Jakarta District Court on Monday (Sep 10) continued the trial of a dispute between Combiphar and Parazelsus regarding the default of the medicine purchase agreement. Panel of the judges, on the trial, gave Combiphar a chance to submit its response in a defense statement.
Bisnis Indonesia reported that instead of proceeding the legal battle with a counter plea, Rully Simorangkir, lawyer of Combiphar, wants to make an amicable settlement. Rully also admitted that he has contacted Parazelsus???s lawyer related to the settlement plan.
Amandri, lawyer of Parazelsus, on the other side, insists that the South Jakarta District Court has no authority to adjudicate the case.
The case started after Combiphar filed a lawsuit against Parazelsus as the company claimed that Parazelsus is in default of the medicine purchase agreement. In the lawsuit, Combiphar demands the judges to order Parazelsus paying Rp3.4 billion as compensation and claimed that Parazelsus yet to make the payment for the medicine received on August 2010 up to October 2011.
Rully explained that there are clauses in the purchase agreement regulating that the payment should be made within 3 months after the medicine received. Parazelsus, according to Rully, also ignored the warning and notification submitted by his client.
On the other side, lawyer of PT Parazelsus, Tony Budidjaja, claimed that Indonesian National Board of Arbitration (BANI) has issued a verdict regarding this issue. The arbitration board has ordered Combiphar to pay Rp3.8 billion compensation for Parazelsus??? medicine distribution. Tony also asked Combiphar to obey the arbitration verdict. (indra@theindonesiatoday.com)